Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma

Bone Marrow Transplant. 2022 Oct;57(10):1623-1625. doi: 10.1038/s41409-022-01767-7. Epub 2022 Aug 3.

¹ Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA.
² Department of Medicine, Division of Nephrology, Brigham and Women's Hospital, Boston, MA, USA.
³ Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.
⁵ Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA. msise@partners.org.

No abstract available

Publication types